Mitochondrial Cytochrome c Oxidase Subunit 1 Sequence Variation in Prostate Cancer
Purpose. Mitochondrial DNA (mtDNA) mutations have been described in every adult neoplasm including prostate cancer. There are marked racial differences in mutations within the cytochrome c oxidase subunit 1 (COI) gene in individuals with prostate cancer (PCa). The purpose of this study was to ident...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Scientifica |
| Online Access: | http://dx.doi.org/10.6064/2012/701810 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832568283116601344 |
|---|---|
| author | Takara A. Scott Rebecca S. Arnold John A. Petros |
| author_facet | Takara A. Scott Rebecca S. Arnold John A. Petros |
| author_sort | Takara A. Scott |
| collection | DOAJ |
| description | Purpose. Mitochondrial DNA (mtDNA) mutations have been described in every adult neoplasm including prostate cancer. There are marked racial differences in mutations within the cytochrome c oxidase subunit 1 (COI) gene in individuals with prostate cancer (PCa). The purpose of this study was to identify the variation in COI gene sequence in African and Caucasian Americans with prostate cancer. Methods. We sequenced the COI gene from peripheral blood in 482 prostate cancer patients and 189 controls. All bases that differed from the revised Cambridge Reference Sequence (rCRS) were classified as either silent or missense and the compiled alterations were then compared between races and published reports. Results and Conclusions. We found inherited mtDNA COI missense variants in 8.8% of Caucasian prostate cancer patients (vs. 0.0% controls) and 72.8% of African-American prostate cancer patients (vs. 64.3% controls) A total of 144 COI variants were identified, of which 30 were missense mutations. Of 482 PCa patients, 116 (24.1%) had one or more missense mutations. Further evaluation of this gene and these mutations may allow for the identification of genetically at-risk populations. The high rate of COI mutations in African-Americans may account for some of the racial disparity observed in prostate cancer. |
| format | Article |
| id | doaj-art-42206c7bc4be4fde938cd9ecf38316bf |
| institution | Kabale University |
| issn | 2090-908X |
| language | English |
| publishDate | 2012-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Scientifica |
| spelling | doaj-art-42206c7bc4be4fde938cd9ecf38316bf2025-02-03T00:59:22ZengWileyScientifica2090-908X2012-01-01201210.6064/2012/701810701810Mitochondrial Cytochrome c Oxidase Subunit 1 Sequence Variation in Prostate CancerTakara A. Scott0Rebecca S. Arnold1John A. Petros2Department of Urology, Emory University, Atlanta, GA 30322, USADepartment of Urology, Emory University, Atlanta, GA 30322, USADepartment of Urology, Emory University, Atlanta, GA 30322, USAPurpose. Mitochondrial DNA (mtDNA) mutations have been described in every adult neoplasm including prostate cancer. There are marked racial differences in mutations within the cytochrome c oxidase subunit 1 (COI) gene in individuals with prostate cancer (PCa). The purpose of this study was to identify the variation in COI gene sequence in African and Caucasian Americans with prostate cancer. Methods. We sequenced the COI gene from peripheral blood in 482 prostate cancer patients and 189 controls. All bases that differed from the revised Cambridge Reference Sequence (rCRS) were classified as either silent or missense and the compiled alterations were then compared between races and published reports. Results and Conclusions. We found inherited mtDNA COI missense variants in 8.8% of Caucasian prostate cancer patients (vs. 0.0% controls) and 72.8% of African-American prostate cancer patients (vs. 64.3% controls) A total of 144 COI variants were identified, of which 30 were missense mutations. Of 482 PCa patients, 116 (24.1%) had one or more missense mutations. Further evaluation of this gene and these mutations may allow for the identification of genetically at-risk populations. The high rate of COI mutations in African-Americans may account for some of the racial disparity observed in prostate cancer.http://dx.doi.org/10.6064/2012/701810 |
| spellingShingle | Takara A. Scott Rebecca S. Arnold John A. Petros Mitochondrial Cytochrome c Oxidase Subunit 1 Sequence Variation in Prostate Cancer Scientifica |
| title | Mitochondrial Cytochrome c Oxidase Subunit 1 Sequence Variation in Prostate Cancer |
| title_full | Mitochondrial Cytochrome c Oxidase Subunit 1 Sequence Variation in Prostate Cancer |
| title_fullStr | Mitochondrial Cytochrome c Oxidase Subunit 1 Sequence Variation in Prostate Cancer |
| title_full_unstemmed | Mitochondrial Cytochrome c Oxidase Subunit 1 Sequence Variation in Prostate Cancer |
| title_short | Mitochondrial Cytochrome c Oxidase Subunit 1 Sequence Variation in Prostate Cancer |
| title_sort | mitochondrial cytochrome c oxidase subunit 1 sequence variation in prostate cancer |
| url | http://dx.doi.org/10.6064/2012/701810 |
| work_keys_str_mv | AT takaraascott mitochondrialcytochromecoxidasesubunit1sequencevariationinprostatecancer AT rebeccasarnold mitochondrialcytochromecoxidasesubunit1sequencevariationinprostatecancer AT johnapetros mitochondrialcytochromecoxidasesubunit1sequencevariationinprostatecancer |